View the PDF version of the magazine

Table of Contents

  • Gareth Morgan, M.D., Ph.D

From the Director

Dear Readers, I am pleased to share with you my excitement about discoveries in myeloma biology that are unfolding at a rapid rate and raising the bar for effective, precision treatment. As you will learn [...]

  • Janet Aronson

From the Editor

The development of personalized medicine approaches to treating myeloma and related diseases takes center stage in this issue of Myeloma. With a wealth of patient sample-derived data, sophisticated systems for analyzing the data, and talented [...]

  • The bioinformatics team: (left to right) Chris Wardell, team leader, Michael Bauer, Amy Buros, Cody Ashby and Caleb Stein

Big Data Analysis Fuels Personalized Medicine

A truly unique feature of the Myeloma Institute is its wealth of patient-derived clinical and research data. With more than 11,750 patients over a period of 27 years, the Myeloma Institute has amassed a treasure trove [...]

  • Left to right: Patricia Harrison-Yates and Sonja Thornes

Twenty Years and Going Strong

Patricia Harrison-Yates has been a myeloma survivor for a very long time. Twenty years, to be exact. She came to the Myeloma Institute in 1996, underwent two transplants and has been doing well ever since. [...]

  • Bailey McNeill, 17 years old at the time, from Raleigh, North Carolina. McNeill had created a web-based business, Crystals4Cancer.com

We Dig Crystals4Cancer!

Last summer (2015) we shared with our readers a heartwarming story about Bailey McNeill, 17 years old at the time, from Raleigh, North Carolina. McNeill had created a web-based business, Crystals4Cancer.com, to sell her hand-crafted [...]

  • Clonal selection and double-hit events involving tumor suppressor genes underlie relapse in myeloma

publication

Clonal selection and double-hit events involving tumor suppressor genes underlie relapse in myeloma A new publication in Blood (2016 Sep 29;128(13):1735-44, PMID: 27516441) Primary Author: Niels Weinhold, M.D., Assistant Professor Despite the introduction of novel [...]

Our Budget for Research is more than 11.5 million

YOUR SUPPORT ENABLES US TO TURN RESEARCH BREAKTHROUGHS INTO LIFESAVING TREATMENTS This year, we ask you to lend your support for our research in precision medicine and targeted treatment approaches. Our talented team of scientists [...]

  • Left to right: Dr. Gareth Morgan, Owen Stephens and Dr. Niels Weinhold

Not by Chance: Eight NEW Genetic Risk Factors Discovered for Multiple Myeloma

National Human Genome Research Institute, National Institues of Health Dr. Gareth Morgan, professor and director of the Myeloma Institute, Dr. Niels Weinhold, assistant professor and director of genetics at the Myeloma Institute, and [...]

An Active Outdoors Life Despite Myeloma

In July 2007, Jim Dykstra did a lot of hard-core hiking. With his brother and nephew, he hiked to the bottom of the Grand Canyon and back up. It was a grueling three-day hike, and [...]

  • “Now you all find a cure for this Disease”

“Now you all find a cure for this Disease”

This is the message that accompanied a donation from Owen and Cheryl Brown of Marietta, Georgia. Straight-forward and to-the-point.  Given, as was the donation, in the spirit of helping all patients and their families who [...]

  • Holly Langster

‘All in’ for Clinical Care Excellence

Caring, Compassionate, Skilled. These adjectives describe nurses that every patient wants at the bedside. They also apply to Holly Langster, the Myeloma Institute’s director of clinical operations, who joined our team in July. An advanced [...]